Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Pharma Industry Urges UK To Make Good On Its Clinical Trial Promises

Executive Summary

Research-based drug companies are asking for swift implementation of UK clinical trial reforms to ensure the country does not lose out on commercial trial activity amid challenges such as capacity constraints in the NHS and delays in regulatory approvals.

You may also be interested in...

UK Launches Inquiry Into Its Clinical Trials Problems After Pharma Outcry

Stung by criticism from the AstraZeneca and GSK CEOs, the UK government has launched an independent review into commercial clinical trials in the hopes of reversing a steep decline.

Industry Calls For Urgent Action As UK Drops In Global Ranking For Clinical Trials

The UK’s research-based industry association has issued a dire warning over the UK’s “deteriorating ability to attract and deliver industry clinical trials.”

New UK Model Agreements To Streamline Clinical Research

Efforts are on to reduce the time it takes to set up commercial studies in UK hospitals.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts